Nutritional recommendations for preventing coronary heart disease in women: Evidence concerning whole foods and supplements

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 20, Issue 6, 2010, Pages 459-466

  Eilat Adar, S ^a,b,c   Goldbourt, U ^c  

^a MEDSTAR RESEARCH INSTITUTE   (United States)

^b WINGATE INSTITUTE   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Coronary heart disease; Nutrition; Women

Indexed keywords

SITOSTEROL DERIVATIVE; STANOL ESTER;

ADULT; AGED; CORONARY ARTERY DISEASE; DIET; DIET SUPPLEMENTATION; FAT SUBSTITUTE; FEMALE; HUMAN; HYPERLIPOPROTEINEMIA; LOW FAT DIET; MALE; MEDITERRANEAN DIET; MIDDLE AGED; NUTRITIONAL STATUS; REVIEW; RISK FACTOR; SEX DIFFERENCE; WOMEN'S HEALTH;

ADULT; AGED; CORONARY DISEASE; DIET; DIET, FAT-RESTRICTED; DIET, MEDITERRANEAN; DIETARY SUPPLEMENTS; FAT SUBSTITUTES; FEMALE; HUMANS; HYPERLIPOPROTEINEMIAS; MALE; MIDDLE AGED; NUTRITIONAL STATUS; RISK FACTORS; SEX FACTORS; SITOSTEROLS; WOMEN'S HEALTH;

EID: 77954958264     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2010.01.011     Document Type: Review

References (48)

1. Ferdinand K.C. Coronary artery disease in minority racial and ethnic groups in the United States. Am J Cardiol 2006, 97:12A-19A.
2. World Health Organization Preventing chronic diseases: a vital investment 2009, Available at:, World Health Organization, [accessed 12.02.09]. http://www.who.int/features/factfiles/global_burden/en/index.html.
3. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001, 285:2486-2497.
4. Willett W.C. Diet and coronary heart disease. Nutritional epidemiology 1998, 414-466. Oxford University Press, New York. 2nd ed. W.C. Willett (Ed.).
5. Lichtenstein A.H., Appel L.J., Brands M., Carnethon M., Daniels S., Franch H.A., et al. Diet and lifestyle recommendations revision 2006 a scientific statement from the American Heart Association Nutrition Committee. Circulation 2006, 114:82-96.
6. Eurodiet Core Report Available at, [accessed 28.02.09]. http://ec.europa.eu/health/ph_determinants/life_style/nutrition/report01_en.pdf&.
7. Joint WHO/FAO Expert Consultation Diet, nutrition and the prevention of chronic diseases 2003, Available at, World Health Organization, Geneva, Switzerland, [accessed 28.02.09]. http://www.who.int/hpr/NPH/docs/who_fao_expert_report.pdf.
8. British Nutrition Foundation Nutrient requirements and recommendations Available at, [accessed 28.02.09]. http://www.nutrition.org.uk/upload/CVD%20pdf%20for%20website.pdf.
9. National Health and Medical Research Council Nutrient reference values for Australia and New Zealand including recommended dietary intakes Available at:, [accessed 20.12.08]. http://www.nhmrc.gov.au/publications/synopses/n35syn.htm.
10. Trichopoulou A., Kouris-Blazos A., Wahlqvist M.L., Gnardellis C., Lagiou P., Polychronopoulos E., et al. Diet and overall survival in elderly people. BMJ 1995, 311:1457-1460.
11. American Diabetes Association, Bantle J.P., Wylie-Rosett J., Albright A.L., Apovian C.M., et al. Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care 2008, 31(Suppl. 1):S61-S78.
12. Retelny V.S., Neuendorf A., Roth J.L. Nutrition protocols for the prevention of cardiovascular disease. Nutr Clin Pract 2008, 23:468-476.
13. Kelly S.A., Summerbell C.D., Brynes A., Whittaker V., Frost G. Wholegrain cereals for coronary heart disease. Cochrane Database Syst Rev 2007, 18:CD005051.
14. Erkkilä A.T., Lichtenstein A.H. Fiber and cardiovascular disease risk: how strong is the evidence?. J Cardiovasc Nurs 2006, 21:3-8.
15. Dauchet L., Amouyel P., Hercberg S., Dallongeville J. Fruit and vegetable consumption and risk of coronary heart disease: a meta-analysis of cohort studies. J Nutr 2006, 136:2588-2593.
16. Howard B.V., Van Horn L., Hsia J., Manson J.E., Stefanick M.L., Wassertheil-Smoller S., et al. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA 2006, 295:655-666.
17. Mozaffarian D., Rimm E.B. Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA 2006, 296:1885-1899.
18. Harris W.S., Kris-Etherton P.M., Harris K.A. Intakes of long-chain omega-3 fatty acid associated with reduced risk for death from coronary heart disease in healthy adults. Curr Atheroscler Rep 2008, 10:503-509.
19. Goldbourt U., Eilat Adar S. Omega-3 and CHD Risk. Harrison's Principles of Internal Medicine, 17e http://www.accessmedicine.com/updatesContent.aspx%3Faid%3D1001275.
20. Kris-Etherton P.M., Hu F.B., Ros E., Sabaté J. The role of tree nuts and peanuts in the prevention of coronary heart disease: multiple potential mechanisms. J Nutr 2008, 138:1746S-1751S.
21. Food labeling: health claims: soy protein and coronary heart disease. Food and Drug Administration, HHS: final rule: soy protein and coronary heart disease. Fed Regist 1999, 64:57700-57733.
22. Sacks F.M., Lichtenstein A., Van Horn L., Harris W., Kris-Etherton P., Winston M. American Heart Association Nutrition Committee. Soy protein, isoflavones, and cardiovascular health: an American Heart Association Science Advisory for professionals from the Nutrition Committee. Circulation 2006, 113:1034-1044.
23. Katan M.B., Grundy S.M., Jones P., Law M., Miettinen T., Paoletti R. Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels. Mayo Clin Proc 2003, 78:965-978.
24. Patch C.S., Tapsell L.C., Williams P.G., Gordon M. Plant sterols as dietary adjuvants in the reduction of cardiovascular risk: theory and evidence. Vasc Health Risk Manag 2006, 2:157-162.
25. Noakes M., Clifton P., Ntanios F., Shrapnel W., Record I., McInerney J. An increase in dietary carotenoids when consuming plant sterols or stanols is effective in maintaining plasma carotenoid concentrations. Am J Clin Nutr 2002, 75:79-86.
26. Bjelakovic G., Nikolova D., Gluud L.L., Simonetti R.G., Gluud C. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst Rev 2008 Apr 16, (2):CD007176.
27. Sesso H.D., Buring J.E., Christen W.G., Kurth T., Belanger C., MacFadyen J., et al. Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA 2008, 300:2123-2133.
28. Michos E.D., Melamed M.L. Vitamin D and cardiovascular disease risk. Curr Opin Clin Nutr Metab Care 2008, 11:7-12.
29. Hsia J., Heiss G., Ren H., Allison M., Dolan N.C., Greenland P., et al. Calcium/vitamin D supplementation and cardiovascular events. Circulation 2007, 115:846-854.
30. Autier P., Gandini S. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med 2007, 167:1730-1737.
31. Langman L.J., Cole D.E.C. Homocysteine. Crit Rev Clin Lab Sci 1999, 36:365-406.
32. Kark J.D., Selhub J., Adler B., Gofin J., Abramson J.H., Friedman G., et al. Nonfasting plasma total homocysteine level and mortality in middle-aged and elderly men and women in Jerusalem. Ann Intern Med 1999, 131:321-330.
33. Dietrich M., Brown C.J., Block G. The effect of folate fortification of cereal-grain products on blood folate status, dietary folate intake, and dietary folate sources among adult non-supplement users in the United States. J Am Coll Nutr 2005, 24:266-274.
34. Eidelman R.S., Hollar D., Hebert P.R., Lamas G.A., Hennekens C.H. Randomized trials of vitamin E in the treatment and prevention of cardiovascular disease. Arch Intern Med 2004, 164:1552-1556.
35. Bleys J., Miller E.R., Pastor-Barriuso R., Appel L.J., Guallar E. Vitamin-mineral supplementation and the progression of atherosclerosis: a meta-analysis of randomized controlled trials. Am J Clin Nutr 2006, 84:880-887.
36. Shekelle P.G., Morton S.C., Jungvig L.K., Udani J., Spar M., Tu W., et al. Effect of supplemental vitamin E for the prevention and treatment of cardiovascular disease. J Gen Intern Med 2004, 19:380-389.
37. Flores-Mateo G., Navas-Acien A., Pastor-Barriuso R., Guallar E. Selenium and coronary heart disease: a meta-analysis. Am J Clin Nutr 2006, 84:762-773.
38. Ebbing M., Bleie Ø, Ueland P.M., Nordrehaug J.E., Nilsen D.W., Vollset S.E., et al. Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial. JAMA 2008, 300:795-804.
39. Albert C.M., Cook N.R., Gaziano J.M., Zaharris E., MacFadyen J., Danielson E., et al. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease. JAMA 2008, 299:2027-2036.
40. Galan P., Briancon S., Blacher J., Czernichow S., Hercberg S. The SU.FOL.OM3 Study: a secondary prevention trial testing the impact of supplementation with folate and B-vitamins and/or Omega-3 PUFA on fatal and non fatal cardiovascular events, design, methods and participants characteristics. Trials 2008, 9:35.
41. Bønaa K.H., Njølstad I., Ueland P.M., Schirmer H., Tverdal A., Steigen T., et al. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 2006, 354:1578-1588.
42. Lonn E., Yusuf S., Arnold M.J., Sheridan P., Pogue J., Micks M., et al. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 2006, 354:1567-1577.
43. Toole J.F., Malinow M.R., Chambless L.E., Spence J.D., Pettigrew L.C., Howard V.J., et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA 2004, 291:565-575.
44. Lange H., Suryapranata H., De Luca G., Börner C., Dille J., Kallmayer K., et al. Folate therapy and in-stent restenosis after coronary stenting. N Engl J Med 2004, 350:2673-2681.
45. Liem A.H., van Boven A.J., Veeger N.J., Withagen A.J., Robles de Medina R.M., Tijssen J.G., et al. Folic acid on risk diminishment after acute myocardial infarction study group. Efficacy of folic acid when added to statin therapy in patients with hypercholesterolemia following acute myocardial infarction: a randomised pilot trial. Int J Cardiol 2004, 93:175-179.
46. Liem A., Reynierse-Buitenwerf G.H., Zwinderman A.H., Jukema J.W., van Veldhuisen D.J. Secondary prevention with folic acid: effects on clinical outcomes. J Am Coll Cardiol 2003, 41:2105-2113.
47. Schnyder G., Roffi M., Flammer Y., Pin R., Hess O.M. Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial. JAMA 2002, 288:973-979.
48. Schnyder G., Roffi M., Pin R., Flammer Y., Lange H., Eberli F.R., et al. Decreased rate of coronary restenosis after lowering of plasma homocysteine levels. N Engl J Med 2001, 345:1593-1600.